Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>
Abnormal returns in stock markets are subject to many studies. In particular, the ability to test on specific industries has received much attention. The number of M&As have increased in the last decade, which also includes M&A deals in the pharmaceutical (pharma) industry, where companies acquire to reach distinctive capabilities to survive in the dynamic and complex business environment. Companies also utilize M&A to increase their ability to create shareholder wealth, though this has shown partially not to be correct. Previous studies conducted, have found rather different results on M&A transactions. This thesis examines the impact on shareholder wealth in pharmaceutical M&As, more precise the study tests the abnormal stock return around the announcement day. The study is conducted with a data sample consisting of 250 deals in the pharma industry between 2000 and 2014.
| Autorius: | Jimmy Thien Phu Nguyen, Thomas Grauer Nielsen, |
| Leidėjas: | LAP Lambert Academic Publishing |
| Išleidimo metai: | 2017 |
| Knygos puslapių skaičius: | 80 |
| ISBN-10: | 3330070439 |
| ISBN-13: | 9783330070431 |
| Formatas: | 220 x 150 x 6 mm. Knyga minkštu viršeliu |
| Kalba: | Anglų |
Parašykite atsiliepimą apie „Mergers & Acquisitions in the Pharmaceutical Industry: An empirical study of acquirers ability to create shareholder wealth“
